Device Generic Name: Pathogen Reduction System for Plasma
Tradename: INTERCEPT Blood System for Plasma
Manufacturer: Cerus Corporation
- Intended to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or apheresis plasma in order to reduce the risk of transfusion-transmitted infection (TTI).
Approval Date: December 16, 2014